MX2022001356A - Microparticulas similares a pelotas de golf para uso en el tratamiento y prevencion de enfermedades pulmonares. - Google Patents
Microparticulas similares a pelotas de golf para uso en el tratamiento y prevencion de enfermedades pulmonares.Info
- Publication number
- MX2022001356A MX2022001356A MX2022001356A MX2022001356A MX2022001356A MX 2022001356 A MX2022001356 A MX 2022001356A MX 2022001356 A MX2022001356 A MX 2022001356A MX 2022001356 A MX2022001356 A MX 2022001356A MX 2022001356 A MX2022001356 A MX 2022001356A
- Authority
- MX
- Mexico
- Prior art keywords
- prevention
- treatment
- golf ball
- microparticles
- pulmonary diseases
- Prior art date
Links
- 208000019693 Lung disease Diseases 0.000 title abstract 2
- 239000011859 microparticle Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 238000000889 atomisation Methods 0.000 abstract 1
- 239000002105 nanoparticle Substances 0.000 abstract 1
- 239000006070 nanosuspension Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE20195603A BE1027612B1 (fr) | 2019-09-10 | 2019-09-10 | Microparticules en forme de balle de golf pour une utilisation dans le traitement et la prevention de maladies pulmonaires |
| PCT/EP2020/075416 WO2021048322A1 (fr) | 2019-09-10 | 2020-09-10 | Microparticules de type balle de golf destinées à être utilisées dans le traitement et la prévention de maladies pulmonaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022001356A true MX2022001356A (es) | 2022-07-19 |
Family
ID=68426040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022001356A MX2022001356A (es) | 2019-09-10 | 2020-09-10 | Microparticulas similares a pelotas de golf para uso en el tratamiento y prevencion de enfermedades pulmonares. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230218515A1 (fr) |
| EP (2) | EP4003320B1 (fr) |
| KR (1) | KR20220050951A (fr) |
| CN (1) | CN114364374A (fr) |
| BE (1) | BE1027612B1 (fr) |
| BR (1) | BR112022003696A2 (fr) |
| CA (1) | CA3150551C (fr) |
| ES (1) | ES2942901T3 (fr) |
| MX (1) | MX2022001356A (fr) |
| WO (1) | WO2021048322A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102665978B1 (ko) * | 2021-11-22 | 2024-05-13 | 충북대학교 산학협력단 | 딤플 구조의 표면을 가진 마이크로 입자의 제조 방법 |
| BE1029585B1 (fr) * | 2021-12-20 | 2023-02-03 | Aquilon Pharmaceuticals | Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire |
| WO2023118014A1 (fr) | 2021-12-20 | 2023-06-29 | Aquilon Pharmaceuticals | Compositions inhalables comprenant un complexe de hpbcd et de budésonide ou de ciclésonide pour le traitement ou la prévention d'une maladie virale respiratoire ou d'une inflammation induite par des lipopolysaccharides, en particulier une inflammation induite par lipopolysaccharides associée à une maladie virale respiratoire |
| BE1030002B1 (fr) | 2021-12-29 | 2023-09-01 | Aquilon Pharmaceuticals | Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006200277B2 (en) | 1997-09-29 | 2008-04-10 | Novartis Ag | Perforated microparticles and methods of use |
| FI20002215A0 (fi) * | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit |
| GB0228826D0 (en) | 2002-12-11 | 2003-01-15 | Okpala Joseph | Hair technology in creating particles with improved delivery capabilities |
| EP1655034A1 (fr) | 2004-10-10 | 2006-05-10 | Université de Liège | Utilisation d'un composé de cyclodextrine pour le traitement et la prévention des maladies inflammatoires bronchiques. |
| CA2615378C (fr) | 2005-07-15 | 2015-02-17 | Map Pharmaceuticals, Inc. | Multiples principes actifs pharmaceutiques combines dans des particules d'inhalation discretes et leurs formulations |
| EP1976486A1 (fr) * | 2006-01-27 | 2008-10-08 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | Procede de production de microparticules poreuses |
| US20150037428A1 (en) | 2011-11-29 | 2015-02-05 | The University Of North Carolina At Chapel Hill | Geometrically engineered particles and methods for modulating macrophage or immune responses |
| MX2015013845A (es) * | 2013-04-01 | 2016-05-09 | Pulmatrix Inc | Polvos secos de tiotropio. |
| EP2923702A1 (fr) | 2014-03-28 | 2015-09-30 | Universite De Liege | Composition de cyclodextrine avec des dérivés de budésonide pour le traitement et la prévention d'une maladie inflammatoire pulmonaire |
| CN106924193A (zh) | 2017-03-20 | 2017-07-07 | 谭淞文 | 一种高孔隙率干粉吸入剂载体及其超饱和合成法和应用 |
-
2019
- 2019-09-10 BE BE20195603A patent/BE1027612B1/fr active IP Right Grant
-
2020
- 2020-09-10 US US17/641,416 patent/US20230218515A1/en active Pending
- 2020-09-10 BR BR112022003696A patent/BR112022003696A2/pt unknown
- 2020-09-10 MX MX2022001356A patent/MX2022001356A/es unknown
- 2020-09-10 EP EP20780106.9A patent/EP4003320B1/fr active Active
- 2020-09-10 WO PCT/EP2020/075416 patent/WO2021048322A1/fr unknown
- 2020-09-10 CN CN202080063138.XA patent/CN114364374A/zh active Pending
- 2020-09-10 CA CA3150551A patent/CA3150551C/fr active Active
- 2020-09-10 EP EP23152796.1A patent/EP4190321A1/fr active Pending
- 2020-09-10 ES ES20780106T patent/ES2942901T3/es active Active
- 2020-09-10 KR KR1020227009234A patent/KR20220050951A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA3150551C (fr) | 2023-10-10 |
| WO2021048322A1 (fr) | 2021-03-18 |
| BE1027612B1 (fr) | 2021-05-03 |
| US20230218515A1 (en) | 2023-07-13 |
| EP4003320A1 (fr) | 2022-06-01 |
| BE1027612A1 (fr) | 2021-04-27 |
| KR20220050951A (ko) | 2022-04-25 |
| ES2942901T3 (es) | 2023-06-07 |
| EP4003320B1 (fr) | 2023-03-08 |
| CN114364374A (zh) | 2022-04-15 |
| EP4190321A1 (fr) | 2023-06-07 |
| BR112022003696A2 (pt) | 2022-05-24 |
| CA3150551A1 (fr) | 2021-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022001356A (es) | Microparticulas similares a pelotas de golf para uso en el tratamiento y prevencion de enfermedades pulmonares. | |
| CY1120605T1 (el) | Παρασκευασμα ξηρης σκονης που περιλαμβανει εναν αναστολεα φωσφοδιεστερασης | |
| MY196072A (en) | Liquid Inhalation Formulation Comprising RPL554 | |
| PH12018502530A1 (en) | Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animals | |
| WO2010111680A3 (fr) | Formulations de poudre sèche et méthodes pour traiter des maladies pulmonaires | |
| EA201291306A1 (ru) | Состав сухого порошка, содержащий антимускариновое средство | |
| GEP20186865B (en) | Dry powder inhaler and inhalation actuated mechanism thereof | |
| WO2014078575A3 (fr) | Nouveaux composés de modulation de régulation de la respiration oralement biodisponibles et leurs procédés d'utilisation | |
| WO2014141210A3 (fr) | Cellules souches de pulpe dentaire immatures multifonctionnelles et applications thérapeutiques | |
| ZA202104378B (en) | Dry powder inhalation formulation and its use for the therapeutic treatment of lungs | |
| HUE044731T2 (hu) | Formulációk a száj, torok és respiratorikus traktus rendellenességeinek kezelésére | |
| PH12016500608A1 (en) | Cyclic thienouracil-carboxamides and use thereof | |
| WO2016032148A3 (fr) | Particules de chitosane conjuguées à de la kartogénine présentant des améliorations en termes de libération prolongée et de biocompatibilité, et leur utilisation | |
| RU2016133264A (ru) | Ускоритель продуцирования катехоламина и терапевтическое и профилактическое средство и терапевтическая и профилактическая пищевая композиция для заболеваний, обусловленных недостаточностью катехоламина | |
| WO2013181217A3 (fr) | Nouveaux composés et nouvelles compositions pour le traitement de troubles ou de maladies du contrôle de la respiration | |
| SG10201803748VA (en) | Methods and treatment for certain demyelination and dysmyelination-based disorders and/or promoting remyelination | |
| MX2019013570A (es) | Particulas portadoras novedosas para formulaciones de polvo seco para inhalacion. | |
| MX2017004633A (es) | Formulaciones que contienen tiotropio, aminoacidos y acidos, y metodos de estas. | |
| PH12015501179A1 (en) | Fixed dose pharmaceutical composition comprising mometasone and azelastine | |
| EP3842029A4 (fr) | Nanoparticules nanostructurées qui comprennent un ou plusieurs principes actifs pour le traitement de maladies produites par des trypanosomes et pour le traitement de tumeurs d'origine neurale, compositions qui comprenent ces nanoparticules nanostructurées, procédé de préparation et d'utilisation thérapeutiques de ces dernières | |
| EP3685831A4 (fr) | Utilisation de citrate ferrique dans la prévention et/ou le traitement de l'anémie ferriprive chez un patient souffrant d'hyperménorrhée et/ou d'un patient souffrant d'une maladie gynécologique associée à une hyperménorrhée | |
| TN2013000015A1 (en) | Dry powder formulation comprising a phosphodiesterase inhibitor | |
| SG11201809042SA (en) | Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseases | |
| MX2016009916A (es) | Composicion cicatrizante a base de tio2 y tournefortia hirsutissima. | |
| CN103751328A (zh) | 一种治疗黄褐斑的外用中药组合物 |